TrialOpen heart2021
Type 2 myocardial infarction and myocardial injury: eligibility for novel medical therapy to derisk clinical trials.
Robert Sykes et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
2021
this papercites it